Have a personal or library account? Click to login
Therapeutic alliance impact on analgesic outcomes in a real-world clinical setting: An observational study Cover

Therapeutic alliance impact on analgesic outcomes in a real-world clinical setting: An observational study

Open Access
|Oct 2022

References

  1. 1. R. B. Ardito and D. Rabellino, Therapeutic Alliance and outcome of psychotherapy: Historical excursus, measurements, and prospects for research, Front. Psychol. 2(270) (2011) https://doi.org/10.3389/fpsyg.2011.00270
  2. 2. R. M. L. Bascuñán, Cambios en la relación médico-paciente y nivel de satisfacción de los médicos[Changes in physician-patient relationship and medical satisfaction], Rev. Med. Chil. 133(1) (2005) 11–16; https://doi.org/10.4067/S0034-98872005000100002
  3. 3. E. Verlinde, N. De Laender, S. De Maesschalck, M. Deveugele and S. Willems, The social gradient in doctor-patient communication, Int. J. Equity Health 11 (2012) Article ID 12 (14 pages); https://doi.org/10.1186/1475-9276-11-12
  4. 4. B. A. Rosser, L. M. McCracken, S. C. Velleman, C. Boichat and C. Eccleston, Concerns about medication and medication adherence in patients with chronic pain recruited from general practice, Pain 152(5) (2011) 1201–1205; https://doi.org/10.1016/j.pain.2011.01.053
  5. 5. A. R. Bethea, M. C. Acosta and D. L. Haller, Patient versus therapist alliance: Whose perception matters?, J. Subst. Abuse Treat. 35(2) (2008) 174–183; https://doi.org/10.1016/j.jsat.2007.09.007
  6. 6. Z. J. Zhong, J. Nie, X. Xie and K. Liu, How medic-patient communication and relationship influence Chinese patients’ treatment adherence, J. Health Commun. 29(1) (2019) 29–37; https://doi.org/10.1080/10810730.2018.1561768
  7. 7. R. H. Dworkin, D. C. Turk, J. T. Farrar, J. A. Haythornthwaite, M. P. Jensen, N. P. Katz, R. D. Kerns, G. Stucki, R. R. Allen, N. Bellamy, D. B. Carr, J. Chandler, P. Cowan, R. Dionne, B. S. Galer, S. Hertz, A. R. Jadad, L. D. Kramer, D. C. Manning, S. Martin, C. G. McCormick, M. P. McDermott, P. Mc-Grath, S. Quessy, B. A. Rappaport, W. Robbins, J. P. Robinson, M. Rothman, M. A. Royal, L. Simon, J. W. Stauffer, W. Stein, J. Tollett, J. Wernicke and J. Witter (IMMPACT), Core outcome measures for chronic pain clinical trials: IMMPACT recommendations, Pain 113(1–2) (2005) 9–19; https://doi.org/10.1016/j.pain.2004.09.012
  8. 8. J. Hardt, C. Jacobsen, J. Goldberg, R. Nickel and D. Buchwald, Prevalence of chronic pain in a representative sample in the United States, Pain Med. 9(7) (2008) 803–812; https://doi.org/10.1111/j.1526-4637.2008.00425.x
  9. 9. A. D. Furlan, R. Reardon and C. Weppler, Opioids for chronic noncancer pain: a new Canadian practice guideline, CMAJ 182(9) (2010) 923–930; https://doi.org/10.1503/cmaj.100187
  10. 10. L. Spooner, K. Fernandes, D. Martins, D. Juurlink, M. Mamdani, J. M. Paterson, S. Singh and T. Gomes, High-dose opioid prescribing and opioid-related hospitalization: A population-based study, PLoS One 11(12) (2016) e0167479; https://doi.org/10.1371/journal.pone.0167479
  11. 11. J. Muriel, C. Margarit, J. Barrachina, P. Ballester, A. Flor, D. Morales, J. F. Horga, E. Fernández and A. M. Peiró, Pharmacogenetics and prediction of adverse events in prescription opioid use disorder patients, Basic Clin. Pharmacol. Toxicol. 124(4) (2019) 439–448; https://doi.org/10.1111/bcpt.13155
  12. 12. L. A. Upp and J. F. Waljee, The opioid epidemic, Clin. Plast. Surg. 47(2) (2020) 181–190; https://doi.org/10.1016/J.CPS.2019.12.005
  13. 13. S. Mercadante, G. Porzio, F. Aielli, C. Adile, L. Verna, C. Ficorella, A. Giarratano and A. Casuccio, Opioid switching from and to tapentadol extended release in cancer patients: Conversion ratio with other opioids, Curr. Med. Res. Opin. 29(6) (2013) 661–666; https://doi.org/10.1185/03007995.2013.791617
  14. 14. K. van Grootheest, S. Olsson, M. Couper and L. de Jong-van den Berg, Pharmacists’ role in reporting adverse drug reactions in an international perspective, Pharmacoepidemiol. Drug Saf. 13(7) (2004) 457–464; https://doi.org/10.1002/pds.897
  15. 15. M. P. Jensen and P. Karoly, Self-Report Scales and Procedures for Assessing Pain in Adults, in Handbook of Pain Assessment (Eds. D. C. Turk and R. Melzack), 3rd ed., The Guilford Press, New York 2011, pp. 19–44.
  16. 16. M. Von Korff, J. Ormel, F. J. Keefe and S. F. Dworkin, Grading the severity of chronic pain, Pain 50(2) (1992) 133–149; https://doi.org/10.1016/0304-3959(92)90154-4
  17. 17. EuroQol Group, EuroQol – a new facility for the measurement of health-related quality of life, Health Policy (New York) 16(3) (1990) 199–208; https://doi.org/10.1016/0168-8510(90)90421-9
  18. 18. J. Lazary, A. Lazary, X. Gonda, A. Benko, E. Molnar, L. Hunyady, G. Juhasz and G. Bagdy, Promoter variants of the cannabinoid receptor 1 gene (CNR1) in interaction with 5-HTTLPR affect the anxious phenotype, Am. J. Med. Genet. Part B 150B(8) (2009) 1118–1127; https://doi.org/10.1002/ajmg.b.31024
  19. 19. S. Vandentorren, E. Le Méner, N. Oppenchaim, A. Arnaud, C. Jangal, C. Caum, C. Vuillermoz, J. Martin-Fernandez, S. Lioret, M. Roze, Y. Le Strat and E. Guyavarch, Characteristics and health of homeless families: The ENFAMS survey in the Paris region, France 2013, Eur. J. Public Health 26(1) (2016) 71–76; https://doi.org/10.1093/eurpub/ckv187
  20. 20. P. Mozzicato, MedDRA: An overview of the medical dictionary for regulatory activities, Pharm. Med. 23(2) (2009) 65–75; https://doi.org/10.1007/BF03256752
  21. 21. C. M. Van Der Feltz-Cornelis, P. Van Oppen, H. W. J. Van Marwijk, E. De Beurs and R. Van Dyck, A patient-doctor relationship questionnaire (PDRQ-9) in primary care: Development and psycho-metric evaluation, Gen. Hosp. Psych. 26(2) (2004) 115–120; https://doi.org/10.1016/j.genhosp-psych.2003.08.010
  22. 22. J. Martín-Fernández, M. I. Del Cura-González, T. Gómez-Gascón, E. Fernández-López, G. Pajares-Carabajal and B. Moreno-Jiménez, Satisfacción del paciente con la relación con su médico de familia: un estudio con el Patient-Doctor Relationship Questionnaire [Patient satisfaction with the Patient-Doctor Relationship measured using the Questionnaire (PDRQ-9)], Aten. Prim. 42(4) (2010) 196–203; https://doi.org/10.1016/j.aprim.2009.09.026
  23. 23. D. L. Paulhus, Socially Desirable Responding: The Evolution of a Construct – Psycnet, in The Role of Constructs in Psychological and Educational Measurement (Eds. H. I. Brown, D. N. Jackson and D. E. Wiley), 1st ed., Routledge, Abingdon-on-Thames (UK) 2015, pp. 49–69.
  24. 24. C. G. Shields, L. N. Fuzzell, S. L. Christ and M. S. Matthias, Patient and provider characteristics associated with communication about opioids: An observational study, Patient Educ. Couns. 102(5) (2019) 888–894; https://doi.org/10.1016/j.pec.2018.12.005
  25. 25. J. Cohen, P. Cohen, S. G. West and L. S. Aiken, Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences, Taylor & Francis, London 2013.
  26. 26. R Core Team, R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing, Vienna, 2016; https://www.R-project.org; last access date February 8, 2022.
  27. 27. J. Muriel, C. Margarit, B. Planelles, M. J. Serralta, C. Puga, M. del M. Inda, E. Cutillas, D. Morales, J. F. Horga and A. M. Peiró, OPRM1 influence on and effectiveness of an individualized treatment plan for prescription opioid use disorder patients, Ann. N. Y. Acad. Sci. 1425(1) (2018) 82–93; https://doi.org/10.1111/nyas.13735
  28. 28. C. Margarit, P. Ballester, M.-D.-M. Inda, R. Roca, L. Gomez, B. Planelles, R. Ajo, D. Morales and A. M. Peiro, OPRM1 gene interaction with sleep in chronic pain patients treated with opioids, Pain Physician 22(1) (2019) 97–107; https://doi.org/10.36076/ppj/2019.22.97
  29. 29. J. Muriel, C. Margarit, J. Barrachina, P. Ballester, A. Flor, D. Morales, J. F. Horga, E. Fernández and A. M. Peiró, Pharmacogenetics and prediction of adverse events in prescription opioid use disorder patients, Basic Clin. Pharmacol. Toxicol. 124(4) (2019) 439–448; https://doi.org/10.1111/bcpt.13155
  30. 30. D. Oppenheim, O. Hartmann and S. Dauchy, [Doctor-patient relationship in oncology: how to prevent and solve some conflicts?], Bull. Cancer 95(1) (2008) 27–32; https://doi.org/10.1684/BDC.2007.0475
  31. 31. C. Stavropoulou, Non-adherence to medication and doctor-patient relationship: Evidence from a European survey, Patient Educ. Couns. 83(1) (2011) 7–13; https://doi.org/10.1016/J.PEC.2010.04.039
  32. 32. M. Chan, H. Fang and M. Shah, Factors affecting patient enablement in an Asian setting: a mixed methods study, Singapore Med. J. 61(12) (2019) 647–660; https://doi.org/10.11622/smedj.2019125
  33. 33. M. Bahadori, M. Yaghoubi, E. Haghgoshyie, M. Ghasemi and E. Hasanpoor, Patients’ and physicians’ perspectives and experiences on the quality of medical consultations: a qualitative study, Int. J. Evid-Based Healthc. 18(2) (2019) 247–255; https://doi.org/10.1097/xeb.0000000000000210
  34. 34. E. Pick, J. R. Kleinbub, S. Mannarini and A. Palmieri, Empathy in neurodegenerative diseases: A systematic review, Neuropsychiatr. Dis. Treat. 2019(15) (2019) 3287–3304, https://doi.org/10.2147/NDT.S225920
  35. 35. B. Planelles, C. Margarit, R. Ajo, Y. Sastre, J. Muriel, M. del M. Inda, M. D. Esteban and A. M. Peiró, Health benefits of an adverse events reporting system for chronic pain patients using long-term opioids, Acta Anaesthesiol. Scand. 63(2) (2019) 248–258; https://doi.org/10.1111/aas.13243
  36. 36. B. Ranque and O. Nardon, Medically unexplained symptoms’ care in internal medicine: A paradigm of doctor-patient relationship in situation of uncertainty, Rev. Med. Intern. 38(7) (2017) 458–466; https://doi.org/10.1016/j.revmed.2016.12.005
  37. 37. S. Pieretti, A. Di Giannuario, R. Di Giovannandrea, F. Marzoli, G. Piccaro, P. Minosi and A. M. Aloisi, Gender differences in pain and its relief, Ann. Ist. Super. Sanita 52(2) (2016) 184–189; https://doi.org/10.4415/ANN_16_02_09
  38. 38. B. Planelles, C. Margarit, M. del M. Inda, P. Ballester, J. Muriel, J. Barrachina, R. Ajo, M. D. Esteban and A. M. Peiró, Gender based differences, pharmacogenetics and adverse events in chronic pain management, Pharmacogenomics J. 20(2) (2020) 320–328; https://doi.org/10.1038/s41397-019-0118-9
  39. 39. R. J. Traub and Y. Ji, Sex differences and hormonal modulation of deep tissue pain, Front. Neuroendocrinol. 34(4) (2013) 350–366; https://doi.org/10.1016/j.yfrne.2013.07.002
  40. 40. M. T. Ruiz-Cantero and M. Verdú-Delgado, Sesgo de género en el esfuerzo terapéutico [Gender bias in treatment], Gac. Sanit. 18(Suppl. 1) (2004) 118–125; https://doi.org/10.1157/13062260
  41. 41. S. Jaworska and K. Ryan, Gender and the language of pain in chronic and terminal illness: A corpus-based discourse analysis of patients’ narratives, Soc. Sci. Med. 215 (2018) 107–114; https://doi.org/10.1016/j.socscimed.2018.09.002
  42. 42. C. Margarit, R. Roca, M. D. M. Inda, J. Muriel, P. Ballester, A. Flor, D. Morales and A. M. Peiró, Gender bias and genotype influence on opioid safety profile in chronic low back pain, Clin. J. Pain36(6) (2020) 420–429; https://doi.org/10.1097/AJP.0000000000000824
  43. 43. M. Kinney, J. Seider, A. F. Beaty, K. Coughlin, M. Dyal and D. Clewley, The impact of therapeutic alliance in physical therapy for chronic musculoskeletal pain: A systematic review of the literature, Physiother. Theory Pract. 36(8) (2018) 886–898; https://doi.org/10.1080/09593985.2018.1516015
  44. 44. A. C. T. Manzoni, N. T. B. de Oliveira, C. M. N. Cabral and N. A. Ricci, The role of the therapeutic alliance on pain relief in musculoskeletal rehabilitation: A systematic review, Physiother. Theory Pract. 34(12) (2018) 901–915; https://doi.org/10.1080/09593985.2018.1431343
  45. 45. L. Manchikanti, A. M. Kaye, N. N. Knezevic, H. McAnally, K. V. Slavin, A. M. Trescot, S. Blank, V. Pampati, S. Abdi, J. S. Grider, A. D. Kaye, K. N. Manchikanti, H. J. Cordner, C. G. Gharibo, M. E. Harned, S. L. Albers, S. Atluri, S. M. Aydin, S. Bakshi, R. Barkin, R. M. Benyamin, M. V. Boswell, R. M. Buenaventura, A. K. Calodney, D. L. Cedeno, S. Datta, T. R. Deer, B. Fellows, V. Galan, V. Grami, H. Hansen, S. Helm II, R. Justiz, D. Koyyalagunta, Y. Malla, A. Navani, K. Nouri, R. Pasupuleti, N. Sehgal, S. M. Silverman, T. T. Simopoulos, V. Singh, D. R. Solanki, P. S. Staats, R. Vallejo, B. W. Wargo, A. Watanabe and J. A. Hirsch, Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: American society of interventional pain physicians (ASIPP) guidelines, Pain Physician 20(2) (2017) S3–S92; https://doi.org/10.36076/ppj.2017.s92
  46. 46. L. Cánovas, A.-J. Carrascosa, M. García, M. Fernández, A. Calvo, V. Monsalve and J.-F. Soriano, (on behalf of the Empathy Study Group), Impact of empathy in the patient-doctor relationship on chronic pain relief and quality of life: A prospective study in Spanish pain clinics, Pain Med. 19(7) (2018) 1304–1314; https://doi.org/10.1093/PM/PNX160
  47. 47. M. Braš, J. Dubravac, V. Dorđević and N. Pjevač, Perception of communication between doctors and patients – On-line research among doctors in Croatia, Med. Acad. Mostar. 6(1-2) (2018) 79–83; Psychiatr. Danub. 31(Suppl. 1) (2019) S79–S83.
  48. 48. R. Z. Pinto, M. L. Ferreira, V. C. Oliveira, M. R. Franco, R. Adams, C. G. Maher and P. H. Ferreira, Patient-centred communication is associated with positive therapeutic alliance: a systematic review, J. Physiother. 58(2) (2012) 77–87; https://doi.org/10.1016/S1836-9553(12)70087-5
  49. 49. J. B. Schnur and G. H. Montgomery, A systematic review of therapeutic alliance, group cohesion, empathy, and goal consensus/collaboration in psychotherapeutic interventions in cancer: Uncommon factors?, Clin. Psychol. Rev. 30(2) (2010) 238–247; https://doi.org/10.1016/J.CPR.2009.11.005
  50. 50. T. H. Gallagher and W. Levinson, A prescription for protecting the doctor-patient relationship, Am. J. Manag. Care 10(2) (2004) 61–68.
  51. 51. A. Dewhurst, S. Peters, A. Devereux-Fitzgerald and J. Hart, Physicians’ views and experiences of discussing weight management within routine clinical consultations: A thematic synthesis, Patient Educ. Couns. 100(5) (2017) 897–908; https://doi.org/10.1016/j.pec.2016.12.017
  52. 52. D. R. Adams, A. Flores, A. Coltri, D. O. Meltzer and V. M. Arora, A missed opportunity to improve patient satisfaction? patient perceptions of inpatient communication with their primary care physician, Am. J. Med. Qual. 31(6) (2016) 568–576; https://doi.org/10.1177/1062860615593339
  53. 53. H. Chamsi-Pasha and M. A. Albar, Doctor-patient relationship: Islamic perspective, Saudi Med. J. 37(2) (2016) 121–126; https://doi.org/10.15537/smj.2016.2.13602
  54. 54. T. Kairuz, L. Bye, R. Birdsall, T. Deng, L. Man, A. Ross, I. Samarasinha and E. Tautolo, Identifying compliance issues with prescription medicines among older people: a pilot study, Drugs Aging 25(2) (2008) 153–162; https://doi.org/10.2165/00002512-200825020-00007
  55. 55. S. G. Henry and M. S. Matthias, Patient-clinician communication about pain: A conceptual model and narrative review, Pain Med. 19(11) (2018) 2154–2165; https://doi.org/10.1093/pm/pny003
  56. 56. K. F. Giannitrapani, M. C. Haverfield, N. K. Lo, M. D. McCaa, C. Timko, S. K. Dobscha, R. D. Kerns and K. A. Lorenz, “Asking is never bad, I would venture on that”: Patients’ perspectives on routine pain screening in VA primary care, Pain Med. 21(10) (2020) 2163–2171; https://doi.org/10.1093/pm/pnaa016
DOI: https://doi.org/10.2478/acph-2022-0035 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 529 - 545
Accepted on: Mar 19, 2022
Published on: Oct 18, 2022
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2022 Jordi Barrachina, César Margarit, Blanca Andreu, Thomas Zandonai, Pura Ballester, Javier Muriel, Esperanza Cutillas, Ana M. Peiró, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.